Multiple findings indicate that GNG12 not only is a biomarker for glioma subtypes but also may promote tumour progression and that GNG12, which targets miR-876-5p, promotes the malignant progression of gliomas by increasing PI3K/AKT signalling activity39. Here, AKT1 is linked to central nervous system cancer.